The shares of this animal protein manufacturer came into focus after the company announced acquisition of a 51 percent controlling stake in multiple companies.
Stock Performance
With a market capitalization of Rs 992.40 crore, Mukka Proteins Ltd fell 2 percent in Wednesday’s trading session to a low of Rs 32.92 per share compared to its previous closing price of Rs 33.60 per share.
What Happened
Mukka Proteins Ltd announced the acquisition of a 51 percent stake in GSM Marine Export, a specialized manufacturer of fish meal and fish oil. The total investment made was Rs 14 crore. With this, Mukka Proteins can strengthen processing, secure raw material supply, and boost its capacity to meet growing global demand in aquafeed, poultry feed, and pet nutrition.
The company also acquired a 51 percent stake in FABBCO BioCycle and Bio Protein Technology Private Limited (FABBCO), whose expertise is insect-based protein production. The total investment made was Rs 6 crore. This move will help Mukka Proteins to cater to the increasing demand for sustainable protein sources for the global aquafeed and livestock industry.
Company Overview
Mukka Proteins is a manufacturer of Fish Protein products such as fish meal, fish oil, and fish soluble paste. These ingredients are used for aqua feed, poultry feed, pet food, pharmaceuticals, soap, leather, and paint industries. It distributes products within India and exports them to more than 20 countries, including South Korea, China, Saudi Arabia and Vietnam.
Financial Performance
In the latest quarter, Mukka Proteins reported a 41 percent decrease in revenue from Rs 517 crore in Q3 FY24 to Rs 303 crore in Q3 FY25. The net profits however saw a massive 125 percent growth from Rs 12 crore to Rs 27 crore during the same period.
Written by Shwetha Sairam
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
